Tcr2 Therapeutics Inc logo

Tcr2 Therapeutics Inc Share Price Today (NASDAQ: TCRR)

Tcr2 Therapeutics Inc share price is $0 & ₹0.00 as on 29 May 2023 IST

▲

-1.48

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 30 May 2023

View live Tcr2 Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Tcr2 Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tcr2 Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Tcr2 Therapeutics Inc (TCRR) Key Statistics

in dollars & INR

Previous Close
$1.48
Open
$1.58
Market Capitalization
$62.0M
Today's Volume
$3.9M
Revenue TTM
$0.0
EBITDA
$-129.0M
Earnings Per Share (EPS)
$-3.79
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.46%

How to invest in Tcr2 Therapeutics Inc Stock (TCRR) from India?

It is very easy for Indian residents to invest directly in Tcr2 Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tcr2 Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tcr2 Therapeutics Inc or TCRR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tcr2 Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tcr2 Therapeutics Inc shares which would translate to null fractional shares of Tcr2 Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Tcr2 Therapeutics Inc, in just a few clicks!

Global Institutional Holdings in Tcr2 Therapeutics Inc

  • Mpm Asset Management, LLC

    10.32%

  • TANG CAPITAL MANAGEMENT LLC

    8.66%

  • MPM Oncology Impact Management LP

    8.59%

  • Vanguard Group Inc

    3.74%

  • Newtyn Management LLC

    2.74%

  • Acadian Asset Management LLC

    2.23%

Analyst Recommendation on Tcr2 Therapeutics Inc

Rating
Trend

Hold

    46%Buy

    53%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Tcr2 Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Tcr2 Therapeutics Inc

TCR2 Therapeutics Inc., a clinical-stage cell therapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. Its lead product candidate is gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin-expressing solid tumors, which is in Phase 1/2 clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma and acute myeloid leukemia. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Tcr2 Therapeutics Inc
Employees
58
CEO
Dr. Garry E. Menzel M.B.A., Ph.D.
Industry
Pharmaceuticals: Major

Important FAQs about investing in TCRR Stock from India :

Can Indians buy Tcr2 Therapeutics Inc shares?

Yes, Indians can invest in the Tcr2 Therapeutics Inc (TCRR) from India.

With INDmoney, you can buy Tcr2 Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tcr2 Therapeutics Inc at zero transaction cost.

How can I buy Tcr2 Therapeutics Inc shares from India?

It is very easy to buy Tcr2 Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tcr2 Therapeutics Inc (TCRR) be purchased?

Yes, you can buy fractional shares of Tcr2 Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Tcr2 Therapeutics Inc stocks?

To start investing in Tcr2 Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Tcr2 Therapeutics Inc?

Today's market capitalisation of Tcr2 Therapeutics Inc TCRR is 62.0M

Who is the Chief Executive Officer (CEO) of Tcr2 Therapeutics Inc ?

Dr. Garry E. Menzel M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Tcr2 Therapeutics Inc.